Image

A 24-month Outcomes of Single- Vs Multiple-visit Revascularization

A 24-month Outcomes of Single- Vs Multiple-visit Revascularization

Recruiting
7-13 years
All
Phase N/A

Powered by AI

Overview

The current randomized clinical trial will be conducted to evaluate the 24-month clinical and radiographic outcomes after revascularization of asymptomatic necrotic immature permanent maxillary incisors using single- or multiple-visit protocol.

Eligibility

Inclusion Criteria:

  • Compliant healthy patients who had at least one immature maxillary permanent incisor requiring nonsurgical root canal treatment.
  • Patients presenting with a diagnosis of pulp necrosis with chronic apical periodontitis confirmed by history, clinical, radiographic and operative examination.
  • Patient without previous endodontic treatment in affected tooth.

Exclusion Criteria:

  • Patients with systemic conditions (medical, developmental or behavioral) that make routine dental treatment difficult.
  • Patients taking medications that can interfere with healing or hemostasis.
  • Patients with allergy to local anesthetics
  • Children who will not comply to recall program.
  • Teeth with extensive loss of coronal tissue that require restoration with a post
  • Teeth with internal or external root resorption

Study details
    Necrotic Immature Permanent Incisors

NCT06762821

Minia University

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.